Efficacy of hypomethylating agents in therapy-related myelodysplastic syndromes Journal Article


Authors: Klimek, V. M.; Dolezal, E. K.; Tees, M. T.; Devlin, S. M.; Stein, K.; Romero, A.; Nimer, S. D.
Article Title: Efficacy of hypomethylating agents in therapy-related myelodysplastic syndromes
Abstract: We retrospectively assessed morphologic and cytogenetic responses to 5-azacytidine and decitabine in a cohort of 42 adult therapy-related myelodysplastic syndromes (tMDS) patients treated at Memorial Sloan-Kettering Cancer Center and in 2 industry-sponsored decitabine trials (D0007 and DACO-020). The overall response rate (complete remission. +. marrow CR. +. hematologic improvement) was 38%, including 6 patients with complete remission (14%), 6 with marrow CR with or without hematologic improvement (14%), and 4 with hematologic improvement alone (10%). We conclude that DNA methyltransferase inhibitors showed activity in tMDS that is roughly comparable to that seen in de novo MDS. © 2012 Elsevier Ltd.
Keywords: adult; cancer chemotherapy; cancer survival; treatment outcome; aged; aged, 80 and over; middle aged; leukemia; retrospective studies; acute granulocytic leukemia; major clinical study; overall survival; allogeneic stem cell transplantation; drug withdrawal; unspecified side effect; cancer radiotherapy; outcome assessment; follow up; multiple cycle treatment; antimetabolites, antineoplastic; retrospective study; dna methylation; myelodysplastic syndrome; drug response; remission; 5 aza 2' deoxycytidine; neoplasms, second primary; drug treatment failure; dna (cytosine-5-)-methyltransferase; azacitidine; induction chemotherapy; myelodysplastic syndromes; 5-azacytidine; decitabine; therapy-related cancer
Journal Title: Leukemia Research
Volume: 36
Issue: 9
ISSN: 0145-2126
Publisher: Elsevier Ltd  
Date Published: 2012-09-01
Start Page: 1093
End Page: 1097
Language: English
DOI: 10.1016/j.leukres.2012.04.025
PROVIDER: scopus
PUBMED: 22608310
DOI/URL:
Notes: --- - "Cited By (since 1996): 1" - "Export Date: 1 August 2012" - "CODEN: LERED" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Virginia Klimek
    147 Klimek
  2. Stephen D Nimer
    347 Nimer
  3. Michael Timothy Tees
    2 Tees
  4. Sean McCarthy Devlin
    601 Devlin